Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "Obesity"
Home
Fatigue, Muscle Loss, and Belly Fat: Is Male Menopause Behind Your Middle-Age Changes?
By middle age, many men notice that they tire more easily, gain abdominal fat, or lose muscle mass. They may also experience a noticeable drop in...
10/20/2026, 09:28 ET
Kyungpook National University Hospital Team Wins Back-to-Back Awards at International Congress
A research team led by Professor Yoon Jong-pil of the Department of Orthopedic Surgery at Kyungpook National University Hospital won the Academic...
10/20/2026, 09:28 ET
"You Don’t Have to Starve to Lose Visceral Fat": Obesity Specialist Highlights Two Crucial Daily Habits
Many individuals immediately turn to strict caloric restriction and intense workouts when trying to lose weight.
10/20/2026, 04:08 ET
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul
What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the...
10/16/2026, 22:38 ET
Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug
A domestically developed therapy has entered South Korea’s obesity treatment market, long dominated by imported...
10/16/2026, 22:37 ET
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro
Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
10/16/2026, 04:57 ET
Visceral Fat Threatens Midlife Health: 4 Simple Ways to Cut It
As basal metabolic rate and overall physical activity decline in midlife, body fat accumulates more easily.
10/07/2026, 03:24 ET
To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why
As the adoption of GLP-1 receptor agonist obesity medications such as Wegovy and Mounjaro accelerates, medical experts...
09/23/2026, 22:29 ET
Does Wegovy Triple Depression Risk? Real-World Data from Korean Hospitals Yields Nuanced Findings
A recent observational study indicates that individuals taking popular GLP-1 receptor agonist obesity medications may...
09/15/2026, 10:34 ET
From White House Briefings to Weight Loss: Why U.S. Officials Are Turning to Pickled Cabbage
When U.S. Vice President JD Vance walked into the White House briefing room on March 3, a reporter lobbed an unexpected...
09/15/2026, 10:17 ET
1
2
3
Next